Substance
TIRZEPATIDE
Global reference: every product and company linked to this substance.
- cas: 2023788-19-2
- ncit: C174817
- rxnorm: 2601723
- unii: OYN3CCI6QE
BG-121 · LY-3298176 · LY3298176 · Mounjaro · Tirzepatide [INN] · Tirzepatide [JAN] · Tirzepatide [WHO-DD] · Tirzepatide[USAN] · Zepbound
Revenue by product (4)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ELI LILLY AND COMPANY COMMON STOCK | MOUNJARO | Q2 2026 | $9.9B |
| ELI LILLY AND COMPANY COMMON STOCK | MOUNJARO (AUTOINJECTOR) | Q2 2026 | $9.9B |
| ELI LILLY AND COMPANY COMMON STOCK | ZEPBOUND | Q2 2026 | $4.9B |
| ELI LILLY AND COMPANY COMMON STOCK | ZEPBOUND (AUTOINJECTOR) | Q2 2026 | $4.9B |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (6)
- MOUNJARO · ELI LILLY AND COMPANY COMMON STOCK
- MOUNJARO (AUTOINJECTOR) · ELI LILLY AND COMPANY COMMON STOCK
- MOUNJARO KWIKPEN · ELI LILLY AND COMPANY COMMON STOCK
- ZEPBOUND · ELI LILLY AND COMPANY COMMON STOCK
- ZEPBOUND (AUTOINJECTOR) · ELI LILLY AND COMPANY COMMON STOCK
- ZEPBOUND KWIKPEN · ELI LILLY AND COMPANY COMMON STOCK